GRN and frontotemporal dementia: Beneficial effects of reduced TMEM106B levels have been reported, especially in frontotemporal dementia-related phenotypes in progranulin-deficient mice where the loss of TMEM106B ameliorated abnormal lysosomal phenotypes [33].